Business Today
BT Bazaar
India Today
Northeast
India Today Gaming
Cosmopolitan
Harper's Bazaar
Brides Today
Ishq FM
Aaj Tak
GNTTV
Kisan Tak
Lallantop
Malyalam
Bangla
Sports Tak
Crime Tak
Aajtak Campus
Astro tak
Subscribe
Home
BT500
Magazine
Cover Story
Editor's Note
Deep Dive
Interview
The Buzz
BT TV
Market Today
Easynomics
Drive Today
BT Explainer
Market Today
Trending Stocks
Indices
Stocks List
Stocks News
Share Market News
IPO Corner
Tech Today
Unbox Today
Authen Tech
Tech Deck
Tech Shorts
Money Today
Tax
Investment
Insurance
Tools & Calculator
Mutual Funds
Industry
Banking
IT
Auto
Energy
Commodities
Pharma
Real Estate
Telecom
Visual Stories
BT Reels
events
Special
PMS Today
Budget 2025
US News
India
Weather
BT Shorts
NRI
Education
Election
Search
Advertisement
Home
Market
BT TV
Reels
Menu
Business News
from the newspapers
'We are not selling Nirula's in a hur
'We are not selling Nirula's in a hur
Join Our WhatsApp Channel
Economic Times
Updated Mar 7, 2011 3:46 PM IST
Published on: Mar 7, 2011 3:46 PM IST
Follow Us on
Channel
Post a comment
0
TOP STORIES
Infosys clarifies ADR rally, denies material developments after 56% surge to $30 in NYSE trade
Fortis Healthcare to invest Rs 840 crore in Bengaluru; firm acquires People Tree Hospital
Symbiotec Pharmalab files draft papers with SEBI for Rs 2,180 crore IPO; key details
Cold wave, dense fog in Delhi-NCR: Flight ops disrupted across north India, over 129 flights cancelled today
Coffee prices under pressure: Robusta and arabica coffee prices slip due to bumper crop
TOP VIDEOS
11:14
Oneweb 2027 Plans: New Tech, New Features
2:32
Vinit Bolinjkar's 2026 Market Strategy: Be Selective And Valuation-Driven
4:27
Accenture Results Spark Fresh Buzz In IT, Early Turn Or Just A Bounce?
2:25
Hate Speech Bill Sparks Chaos In Karnataka Assembly, Opposition Cries Free Speech Attack
2:21
High-Profile Names Appear In New Epstein Photo Release Ahead Of Deadline
Fortis Healthcare to invest Rs 840 crore in Bengaluru; firm acquires People Tree Hospital
Infosys clarifies ADR rally, denies material developments after 56% surge to $30 in NYSE trade
Symbiotec Pharmalab files draft papers with SEBI for Rs 2,180 crore IPO; key details
Infosys trading: Infosys ADR 40% spike traced to data error, algo trading, says report
NYSE suspends trading of Infosys ADRs after 40% surge; Wipro ADRs soar